Hospitalized patients' infections may develop from their own bacteria: Study Dr. Nandita Mohan16 Jan 2023 12:16 PM GMTHospitals have strict hygiene and sanitation protocols to protect patients from bacteria that rarely sicken healthy people but can be deadly for...
Health Bulletin 16/January/2023 Dr. Nandita Mohan16 Jan 2023 10:44 AM GMTHere are the top health stories for the day:Formulate stringent guidelines to regulate antenatal USG protocols: NCDRC directs NMC upholding medical...
COVID intranasal vaccine: Bharat Biotech iNCOVACC priced at Rs 800 for private hospitals, Rs 325 for Govt Ruchika Sharma27 Dec 2022 9:00 AM GMTiNCOVACC is the world's first intranasal vaccine for COVID to receive approval for the primary two-dose schedule, and as a heterologous booster dose.
Centre nod to Bharat Biotech nasal COVID vaccine iNCOVACC, to be availabile in private hospitals Ruchika Sharma23 Dec 2022 10:01 AM GMTiNCOVACC is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion stabilized SARS-CoV-2 spike protein.
Bharat Biotech Chairman says Intranasal vaccine iNCOVACC will be global game changer Ruchika Sharma7 Sep 2022 5:30 AM GMTiNCOVACC has been specifically formulated to allow intranasal delivery through nasal drops.
Bharat Biotech, Washington varsity join hands for intranasal COVID vaccine MD Bureau24 Sep 2020 7:15 AM GMTHyderabad: Leading vaccine maker Bharat Biotech on Wednesday announced a licensing agreement with Washington University School of Medicine in St....
